MELD Score Is an Important Predictor of Pretransplantation Mortality in HIV-Infected Liver Transplant Candidates

Gastroenterology

Volumn 138, Issue 1, 2010, Pages 159-164

  Subramanian, Aruna ^a   Sulkowski, Mark ^a   Barin, Burc ^b   Stablein, Donald ^b   Curry, Michael ^c   Nissen, Nicholas ^d   Dove, Lorna ^e   Roland, Michelle ^f   Florman, Sander ^g   Blumberg, Emily ^h   Stosor, Valentina ⁱ   Jayaweera, D T ^j   Huprikar, Shirish ^k   Fung, John ^l   Pruett, Timothy ^m   Stock, Peter ⁿ   Ragni, Margaret ^o  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b EMMES CORPORATION   (United States)

^c BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^d CEDARS SINAI MEDICAL CENTER   (United States)

^e New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^f CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

^g TULANE UNIVERSITY MEDICAL CENTER   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

ⁱ NORTHWESTERN UNIVERSITY   (United States)

^j UNIVERSITY OF MIAMI   (United States)

^k MOUNT SINAI HOSPITAL   (United States)

^l LERNER RESEARCH INSTITUTE   (United States)

^m UNIVERSITY OF VIRGINIA   (United States)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o UNIVERSITY OF PITTSBURGH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIVER DISEASE; LIVER TRANSPLANTATION; MALE; MORTALITY; ORGAN TRANSPLANTATION; PREDICTOR VARIABLE; PRIORITY JOURNAL; RACE; RELIABILITY; SCORING SYSTEM;

EID: 72549096099     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2009.09.053     Document Type: Article

References (19)

1. Mocroft A., Soriano V., Rockstroh J., et al. Is there evidence for an increase in the death rate from liver-related disease in patients with HIV?. AIDS 19 (2005) 2117-2125
2. Weber R., Sabin C.A., Friis-Møller N., et al. Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study. Arch Intern Med 166 (2006) 1632-1641
3. Koziel M.J., and Peters M.G. Viral hepatitis and HIV infection. N Engl J Med 356 (2007) 1445-1454
4. Sulkowski M.S., Thomas D.L., Chaisson R.E., et al. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. JAMA 283 (2000) 74-80
5. Sulkowski M.S. Viral hepatitis and HIV coinfection. J Hepatol 48 (2008) 353-367
6. Kamath P.S., Wiesner R.H., Malinchoc M., et al. A model to predict survival in patients with end-stage liver disease. Hepatology 33 (2001) 464-470
7. Kamath P.S., and Kim W.R. The Model for End-Stage Liver Disease (MELD). Hepatology 45 (2007) 797-805
8. Ragni M.V., Eghtesad B., Schlesinger K.W., et al. Pre-transplant survival is shorter in HIV-positive than HIV-negative subjects with end-stage liver disease. Liver Transpl 11 (2005) 1425-1430
9. Pineda J.A., Romero-Gómez M., Díaz-García F., et al. HIV co-infection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology 41 (2005) 779-789
10. Stock P.G. Rapid deterioration of HIV co-infected patients waiting for liver transplantation is not predicted by MELD. Liver Transpl 11 (2005) 1315-1317
11. Pineda J.A., Garcia-Garcia J.A., Aguilar-Guisado M., et al. Clinical progression of hepatitis C virus-related chronic liver disease in human immunodeficiency virus-infected patients undergoing highly active antiretroviral therapy. Hepatology 46 (2007) 622-630
12. Ragni M.V., Belle S.H., Im K., et al. Survival in HIV-infected liver transplant recipients. J Infect Dis 188 (2003) 1412-1420
13. Fung J.J., Eghtesad B., Patel T.K., et al. Liver transplantation in patients with HIV infection. Liver Transplantation 10 Suppl 2 (2004) S39-S53
14. Soriano V., Puoti M., Sulkowski M., et al. Care of patients co-infected with HIV and hepatitis C virus: 2007 updated recommendations from the HCV-HIV International Panel. AIDS 21 (2007) 1073-1089
15. Deuffic-Burban S., Poynard T., Sulkowski M.S., et al. Estimating the future health burden of chronic hepatitis C and human immunodeficiency virus infections in the United States. J Viral Hepatol 14 (2007) 107-115
16. Ragni M.V., and Belle S.H. Impact of human immunodeficiency virus (HIV) on progression to end-stage liver disease in individuals with hemophilia and hepatitis C. J Infect Dis 183 (2001) 1112-1115
17. Ragni M.V., Schillo R., Nalesnik M.A., et al. HAART improves ESLD-free survival in HIV-HCV co-infection. Haemophilia 15 (2009) 552-558
18. Bräu N., Fox R.K., Xiao P., et al. Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a US-Canadian multicenter study. J Hepatol 47 (2007) 527-537
19. Biggins S.W., Kim R.W., Terrault N.A., et al. Evidence-based Incorporation of serum sodium concentration into MELD. Gastroenterology 130 (2006) 1652-1660